Search results
- Regulatory news (469) Apply Regulatory news filter
- Press releases (234) Apply Press releases filter
- Basic page (60) Apply Basic page filter
- Corporate presentations (26) Apply Corporate presentations filter
- Pipeline (26) Apply Pipeline filter
- Shareholder meeting (24) Apply Shareholder meeting filter
- Team member (21) Apply Team member filter
- Videos (16) Apply Videos filter
- Analyst (12) Apply Analyst filter
- Financial reports (12) Apply Financial reports filter
- Webcasts and audio (12) Apply Webcasts and audio filter
- Investor contact (6) Apply Investor contact filter
- Event (3) Apply Event filter
- Research (3) Apply Research filter
- Financial calendar (1) Apply Financial calendar filter
- Webform (1) Apply Webform filter
Oxford Biomedica broadens its viral vector capabilities with the launch of Oxford Biomedica Solutions, a full scope AAV business in Boston, following closing of its deal with Homology
Unique platform offering capabilities from vector design and process development through to clinical trials is now available to new custome
Oxford Biomedica Appoints Namrata P Patel as Non-Executive Director
Oxford, UK – 13 April 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell therapy